Lihong Qu

机构：Shanghai Jiao Tong University, Shanghai East Hospital · ORCID：0000-0001-8631-7882

发表论文 51 篇 · 总被引 462 次 · h-index 12

代表论文

• PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial (2024 · Journal of Hepatology · 被引 24)
• Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study (2024 · BMJ · 被引 18)
• Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial (2024 · Clinical Microbiology and Infection · 被引 16)
• Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma (2024 · Biology Direct · 被引 15)
• Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study (2024 · Frontiers in Microbiology · 被引 13)
• The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB (2023 · Frontiers in Pharmacology · 被引 12)